Skip to main content
SpringerLink
Log in

Mitochondrial Disease: A Historical, Biochemical, and London Perspective

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Roland Luft is credited with describing the first truly mitochondrial disorder in the late 1950s and early 1960s. Cases such as his have proven to be exceptionally rare. Some years later, methods of mitochondrial analysis—enzymatic, polarographic, and spectroscopic, which had been developed primarily by groups in Philadelphia—were applied to the study of mitochondria isolated from skeletal muscle biopsies of patients thought to have defects of oxidative phosphorylation. In the vanguard of these investigations were groups in New York and London. John Clark led the latter group. Application of biochemical studies, more recently supplemented by molecular mtDNA and nuclear DNA studies, have revealed that mitochondrial disorders are among the most common of all metabolic disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ernster, L., Ikkos, D., and Luft, R. 1959. Enzymatic activities of human skeletal muscle mitochondria: A tool in clinical metabolic research. Nature 184:1851–1854.

    PubMed  Google Scholar 

  2. Luft, R., Ikkos, D., Palmieri, G., Ernster, L., and Afzelius, B. 1962. A case of severe hypermetabolism of non-thyroid origin with a defect in the maintenance of mitochondrial respiratory control: A correlated clinical, biochemical and morphological study. J. Clin. Invest. 41:1776–1804.

    PubMed  Google Scholar 

  3. DiMauro, S., Bonilla, E., Lee, C. P., Schottland, D. L., Scarpa, A., Conn, H., and Chance, B. 1976. Luft's disease: Further biochemical and ultrastructural studies of skeletal muscle in the second case. J. Neurol. Sci. 27:217–232.

    PubMed  Google Scholar 

  4. Mitchell, P. 1966. Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Glynn Research Laboratories, Bodmin, UK.

    Google Scholar 

  5. Mitchell, P. 1976. Possible molecular mechanisms of the proton motive function of cytochrome systems. J. Theor. Biol. 62:327–367.

    PubMed  Google Scholar 

  6. Palmer, J. M. 1979. The 'Uniqueness' of Plant Mitochondria. Biochem. Soc. Trans. 7:246–252.

    PubMed  Google Scholar 

  7. Seligman, A. M., Karnovsky, M. J., Wasserkrug, H. L., and Hanker, J. S. 1968. Nondroplet ultrastructural demonstration of cytochrome oxidase activity with a polymerizing osmiophilic reagent, diaminobenzidine (DAB). J. Cell Biol. 38:1–14.

    PubMed  Google Scholar 

  8. Engel, W. and Cunningham, C. 1963. Rapid examination of muscle tissue, an improved trichrome stain method for fresh-frozen biopsy sections. Neurology 13:919–923.

    PubMed  Google Scholar 

  9. Shy, G. M. and Gonatas, N. 1964. Human myopathy with giant abnormal mitochondria. Science 145:493–496.

    PubMed  Google Scholar 

  10. Drachman, D. 1968. Ophthalmoplegia plus: The neurodegenerative disorders associated with progressive external opthalmoplegia. Arch. Neurol. 18:654–674.

    PubMed  Google Scholar 

  11. Morgan-Hughes, J. A., Darveniza, P., Kahn, S. N., Landon, D. N., Sherratt, R. M., Land, J. M., and Clark, J. B. 1977. A mitochondrial myopathy characterized by a deficiency in reducible cytochrome b. Brain 100:617–640.

    PubMed  Google Scholar 

  12. Olson, W., Engle, W. K., Walsh, G. O., and Einaugler, R. 1972. Oculocraniosomatic neuromuscular disease with 'ragged red' fibres. Arch. Neurol. 26:193–211.

    PubMed  Google Scholar 

  13. Schapira, Y., Harel, S., and Russel, A. 1977. A mitochondrial encephalomyopathy: A group of neuromuscular disorders with defects in oxidative metabolism. Israel J. Med. Sci. 13:161–164.

    PubMed  Google Scholar 

  14. Luft, R. 1994. The development of mitochondrial medicine. PNAS 91:8731–8738.

    PubMed  Google Scholar 

  15. Luft, R. 1995. The development of mitochondrial medicine. Biochim. Biophys. Acta. 1271:1–6.

    Google Scholar 

  16. Makinen, M. W. and Lee, C. P. 1968. Biochemical studies of skeletal muscle mitochondria: I. Microanalysis of cytochrome content, oxidative and phosphorylative activies of mammalian skeletal muscle mitochondria. Arch. Biochem. Biophys. 126:75–82.

    PubMed  Google Scholar 

  17. Chance, B. and Hagihara, B. 1960. Biochem. Biophys. Res. Commun. 3:1–5.

    Google Scholar 

  18. Land, J. M. and Clark, J. B. 1979. Mitochondrial myopathies. Biochem. Soc. Trans. 7:231–245.

    PubMed  Google Scholar 

  19. Morgan-Hughes, J. A. and Hanna, M. G. 1999. Mitochondrial encephalomyopathies: The enigma of genotype versus phenotype. Biochim. Biophys. Acta. 1410:125–145.

    PubMed  Google Scholar 

  20. Nass, S. and Nass, M. 1963. Intramitochondrial fibers with DNA characteristics: I. Fixation and electron staining reactions. J. Cell Biol. 19:593–612.

    PubMed  Google Scholar 

  21. Holt, I. J., Harding, A. E., and Morgan-Hughes, J. A. 1988. Deletions of muscle mitochondria DNA in patients with mitochondrial myopathies. Nature 331:717–719.

    PubMed  Google Scholar 

  22. Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M., et al. 1988. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242:1427–1430.

    PubMed  Google Scholar 

  23. Weatherall, D. J. 1982. The New Genetics and Clinical Practise, OUP, Oxford, UK.

    Google Scholar 

  24. Spiro, A. J., Moore, C. L., Prinea, J. W., Strasberg, P. M., and Rapin, I. 1970. A cytochrome-related inherited disorder of the nervous system and muscle. Arch. Neurol. 23:103–112.

    PubMed  Google Scholar 

  25. Andreu, A. L., Hanna, M. G., Reichmann, H., Bruno, C., and Penn, A. S. 1999. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. NEJM 341:1037–1044.

    PubMed  Google Scholar 

  26. Mazat, J. P., Rossignol, R., Malgat, M., Rocher, C., Faustin, B., and Letellier, T. 2001. What do mitochondrial diseases teach us about normal mitochondrial functions ... that we already knew: Threshold expression of mitochondrial defects. Biochim. Biophys. Acta. 1504:20–30.

    PubMed  Google Scholar 

  27. Davey, G. P., Peuchen, S., and Clark, J. B. 1998. Energy thresholds in brain mitochondria: Potential involvement in neurodegeneration. J. Biol. Chem. 273:12753–12757.

    PubMed  Google Scholar 

  28. Munnich, A., Rotig, A., Chretien, D., Cormier, V., Bourgeron, T., Bonnefont, J. P., et al. 1996. Clinical presentation of mitochondrial disorders in childhood. J. Inher. Metab. Dis. 19:521–527.

    PubMed  Google Scholar 

  29. Chinnery, P. F., Johnson, M. A., Wendall, T. M., Singh-Kler, R., Hayes, C., Brown, D. T., et al. 2000. The epidemiology of pathogenic mitochondrial DNA mutations. Ann. Neuro. 48:188–193.

    Google Scholar 

  30. Skladal, D., Halliday, J., and Thorburn, D. R. 2003. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126:1905–1912.

    PubMed  Google Scholar 

  31. Borchert, A., Wolf, N. I., and Wilichowski, E. 2002. Current concepts of mitochondrial disorders in childhood. Semin. Pediatr. Neurol. 9:151–159.

    PubMed  Google Scholar 

  32. Byrne, E. 2002. Does mitochondrial respiratory chain dysfunction have a role in common neurodegenerative disorders? J. Clin. Neurosci. 9:497–450.

    PubMed  Google Scholar 

  33. Calabrese, V., Scapagnini, G., Giuffrida-Stella, A. M., Bates, T. E., and Clark, J. B. 2001. Mitochondrial involvement in brain function and dysfunction: Relevance to aging, neurodegenerative disorders and longevity. Neurochem. Res. 26:739–764.

    PubMed  Google Scholar 

  34. Brealey, D., Brand, M., Hargreaves, I., Heales, S., Land, J., Smolenski, R., et al. 2002. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360:219–223.

    PubMed  Google Scholar 

  35. Harmen, D. 1972. The biologic clock: The mitochondria? J. Am. Geriatr. Soc. 20:145–147.

    PubMed  Google Scholar 

  36. Clark, J. B., Bates, T. E., Boakye, P., Kuimov, A., and Land, J. M. 1996. Investigation mitochondrial defects in brain and skeletal muscle. Pages 151–174, in Turner, A. J. and Batchelard, H. S., (eds.), A Practical Approach to the Investigation of Metabolic Disease. IRL Press, Oxford University Press, Oxford.

    Google Scholar 

  37. Kumps, A., Duez, P., and Mardens, Y. 2002. Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: A comprehensive table. Clin. Chem. 48:708–717.

    PubMed  Google Scholar 

  38. Barth, P. G., Wanders, R. J., Vreken, P., Janssen, E. A., Lam, J., and Baas. F. 1999. X-Linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060). J. Inherit. Metab. Dis 22:555–567.

    PubMed  Google Scholar 

  39. Almeida, A., Brooks, K. J., Sammut, I., Keelan, J., Davey, G. P., Clark, J. B., and Bates, T. E. 1995. Postnatal development of the complexes of the electron transport chain in synaptic mitochondria from rat brain. Dev. Neurosci. 17:212–218.

    PubMed  Google Scholar 

  40. Bates, T. E., Almeida, A., Heales, S. J., and Clark, J. B. 1994. Postnatal development of the complexes of the electron transport chain in isolated rat brain mitochondria. Dev. Neurosci. 16:321–327.

    PubMed  Google Scholar 

  41. Land, J. M., Booth, R. F., Berger, R., and Clark, J. B. 1977. Development of mitochondrial energy metabolism in rat brain. Biochem. J. 164:339–348.

    PubMed  Google Scholar 

  42. Booth, R. F., Patel, T. B., and Clark, J. B. 1980. The development of enzymes of energy metabolism in the brain of a precocial (guinea pig) and non-precocial (rat) species. J. Neurochem. 34:17–25.

    PubMed  Google Scholar 

  43. Lai, J. C., Walsh, J. M., Dennis, S. C., and Clark, J. B. 1977. Synaptic and non-synaptic mitochondria from rat brain: Isolation and characterization. J. Neurochem. 28:625–631.

    PubMed  Google Scholar 

  44. Clark, J. B. and Nicklas, W. J. 1970. The metabolism of rat brain mitochondria: Preparation and characterization. J. Biol. Chem. 245:4724–4731.

    PubMed  Google Scholar 

  45. Lai, J. C. and Clark, J. B. 1979. Preparation of synaptic and non-synaptic mitochondria from mammalian brain. Methods Enzymol. 55:51–60.

    PubMed  Google Scholar 

  46. Booth, R. F. and Clark, J. B. 1978. The control of pyruvate dehydrogenase in isolated brain mitochondria. J. Neurochem. 30:1003–1008.

    PubMed  Google Scholar 

  47. Booth, R. F. and Clark, J. B. 1981. Energy metabolism in rat brain: Inhibition of pyruvate decarboxylation by 3-hydroxybutyrate in neonatal mitochondria. J. Neurochem. 37:179–185.

    PubMed  Google Scholar 

  48. Cullingford, T. E., Clark, J. B., and Phillips, I. R. 1994. The pyruvate dehydrogenase complex: Cloning of the rat somatic E1 alpha subunit and its coordinate expression with the mRNAs for the E1 beta, E2, and E3 catalytic subunits in developing rat brain. J. Neurochem. 62:1682–1690.

    PubMed  Google Scholar 

  49. Byrne, E., Hayes, D. J., Shoubridge, E. A., Morgan-Hughes, J. A., and Clark, J. B. 1985. Experimentally induced defects of mitochondrial metabolism in rat skeletal muscle: Biological effects of the mitochondrial uncoupling agent 2,4-dinitrophenol. Biochem. J. 229:101–18.

    PubMed  Google Scholar 

  50. Hayes, D. J., Byrne, E., Shoubridge, E. A., Morgan-Hughes, J. A., and Clark, J. B. 1985. Experimentally induced defects of mitochondrial metabolism in rat skeletal muscle: Biological effects of the NADH:coenzyme Q reductase inhibitor diphenyleneiodonium. Biochem. J. 229:109–117.

    PubMed  Google Scholar 

  51. Cooper, J. M., Petty, R. K., Hayes, D. J., Challiss, R. A., Brosnan, M. J., Shoubridge, E. A., et al. 1988. An animal model of mitochondrial myopathy: A biochemical and physiological investigation of rats treated in vivo with the NADH-CoQ reductase inhibitor, diphenyleneiodonium. J. Neurol. Sci. 83:335–347.

    PubMed  Google Scholar 

  52. Cooper, J. M., Petty, R. K., Hayes, D. J., Morgan-Hughes, J. A., and Clark, J. B. 1988. Chronic administration of the oral hypoglycaemic agent diphenyleneiodonium to rats: An animal model of impaired oxidative phosphorylation (mitochondrial myopathy). Biochem. Pharmacol. 37:687–694.

    PubMed  Google Scholar 

  53. Bates, T. E., Heales, S. J., Davies, S. E., Boakye, P., and Clark, J. B. 1994. Effects of 1-methyl-4-phenylpyridinium on isolated rat brain mitochondria: Evidence for a primary involvement of energy depletion. J. Neurochem. 63:640–648.

    PubMed  Google Scholar 

  54. Heales, S. J., Davies, S. E., Bates, T. E., and Clark, J. B. 1995. Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochem. Res. 20:31–38.

    PubMed  Google Scholar 

  55. Haines, A. M., Cooper, J. M., Morgan-Hughes, J. A., Clark, J. B., and Schapira, A. H. 1992. One-step immunoaffinity purification of complex subunits from beef heart mitochondria. Protein Expr. Purif. 3:223–227.

    PubMed  Google Scholar 

  56. Schapira, A. H., Cooper, J. M., Morgan-Hughes, J. A., Patel, S. D., Cleeter, M. J., Ragan, C. I., and Clark, J. B. 1988. Molecular basis of mitochondrial myopathies: Polypeptide analysis in complex-I deficiency. Lancet 1:500–503.

    PubMed  Google Scholar 

  57. Cooper, J. M., Hayes, D. J., Challiss, R. A., Morgan-Hughes, J. A., and Clark, J. B. 1992. Treatment of experimental NADH ubiquinone reductase deficiency with menadione. Brain 115:991–1000.

    PubMed  Google Scholar 

  58. White, E. J. and Clark, J. B. 1988. Menadione-treated synaptosomes as a model for post-ischaemic neuronal damage. Biochem. J. 253:425–433.

    PubMed  Google Scholar 

  59. Heales, S. J., Bolanos, J. P., Land, J. M., and Clark, J. B. 1994. Trolox protects mitochondrial complex IV from nitric oxide-mediated damage in astrocytes. Brain Res. 668:243–245.

    PubMed  Google Scholar 

  60. Schapira, A. H., Cooper, J. M., Morgan-Hughes, J. A., Landon, D. N., and Clark, J. B. 1990. Mitochondrial myopathy with a defect of mitochondrial-protein transport. N. Engl. J. Med. 323:37–42.

    PubMed  Google Scholar 

  61. Hardy, L., Clark, J. B., Darley-Usmar, V. M., Smith, D. R., and Stone, D. 1991. Reoxygenation-dependent decrease in mitochondrial NADH:CoQ reductase (complex I) activity in the hypoxic/reoxygenated rat heart. Biochem. J. 274:133–137.

    PubMed  Google Scholar 

  62. Bolanos, J. P., Peuchen, S., Heales, S. J., Land, J. M., and Clark, J. B. 1994. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J. Neurochem. 63:910–916.

    PubMed  Google Scholar 

  63. Rahman, S., Hargreaves, I., Clayton, P., and Heales, S. 2001. Neonatal presentation of coenzyme Q10 deficiency. J. Pediatr. 139:456–458.

    PubMed  Google Scholar 

  64. Burne, J. 2003. The hidden power to heal. The Independent Review, London, April 23, p. 8.

Download references

Author information

Authors and Affiliations

  1. Neurometabolic Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London, England

    John M. Land, Iain Hargreaves & Simon J. R. Heales

  2. Miriam Marks Department of Neurochemistry, Institute of Neurology, Queen Square, London, England

    John M. Land, John A. Morgan-Hughes, Iain Hargreaves & Simon J. R. Heales

Authors
  1. John M. Land
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John A. Morgan-Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Iain Hargreaves
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Simon J. R. Heales
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John M. Land.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Land, J.M., Morgan-Hughes, J.A., Hargreaves, I. et al. Mitochondrial Disease: A Historical, Biochemical, and London Perspective. Neurochem Res 29, 483–491 (2004). https://doi.org/10.1023/B:NERE.0000014819.53972.b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:NERE.0000014819.53972.b0

Search

Navigation